These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24363024)

  • 1. Soypeptide lunasin in cytokine immunotherapy for lymphoma.
    Chang HC; Lewis D; Tung CY; Han L; Henriquez SM; Voiles L; Lupov IP; Pelloso D; Sinn AL; Pollok KE; de Lumen BO; Li F; Blum JS; Srivastava S; Robertson MJ
    Cancer Immunol Immunother; 2014 Mar; 63(3):283-95. PubMed ID: 24363024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.
    Rosario M; Liu B; Kong L; Collins LI; Schneider SE; Chen X; Han K; Jeng EK; Rhode PR; Leong JW; Schappe T; Jewell BA; Keppel CR; Shah K; Hess B; Romee R; Piwnica-Worms DR; Cashen AF; Bartlett NL; Wong HC; Fehniger TA
    Clin Cancer Res; 2016 Feb; 22(3):596-608. PubMed ID: 26423796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of dendritic cell function by soypeptide lunasin as a novel vaccine adjuvant.
    Tung CY; Lewis DE; Han L; Jaja M; Yao S; Li F; Robertson MJ; Zhou B; Sun J; Chang HC
    Vaccine; 2014 Sep; 32(42):5411-9. PubMed ID: 25131731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
    Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
    Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
    Lauwerys BR; Garot N; Renauld JC; Houssiau FA
    J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood.
    Qian JX; Lee SM; Suen Y; Knoppel E; van de Ven C; Cairo MS
    Blood; 1997 Oct; 90(8):3106-17. PubMed ID: 9376592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.
    Uppendahl LD; Felices M; Bendzick L; Ryan C; Kodal B; Hinderlie P; Boylan KLM; Skubitz APN; Miller JS; Geller MA
    Gynecol Oncol; 2019 Apr; 153(1):149-157. PubMed ID: 30658847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-metastatic activity induced by the in vivo activation of purified protein derivative (PPD)-recognizing Th1 type CD4+ T cells.
    Shinomiya Y; Harada M; Kurosawa S; Okamoto T; Terao H; Matsuzaki G; Shirakusa T; Nomoto K
    Immunobiology; 1995 Aug; 193(5):439-55. PubMed ID: 8522359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma.
    Oelsner S; Friede ME; Zhang C; Wagner J; Badura S; Bader P; Ullrich E; Ottmann OG; Klingemann H; Tonn T; Wels WS
    Cytotherapy; 2017 Feb; 19(2):235-249. PubMed ID: 27887866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFα Augments Cytokine-Induced NK Cell IFNγ Production through TNFR2.
    Almishri W; Santodomingo-Garzon T; Le T; Stack D; Mody CH; Swain MG
    J Innate Immun; 2016; 8(6):617-629. PubMed ID: 27560480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation and biological activity of interleukin 12.
    Lee SM; Suen Y; Qian J; Knoppel E; Cairo MS
    Leuk Lymphoma; 1998 May; 29(5-6):427-38. PubMed ID: 9643557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenite suppresses IL-2-dependent tumoricidal activities of natural killer cells.
    Sumi D; Tsuyama H; Ogawa T; Ogawa M; Himeno S
    Toxicol Appl Pharmacol; 2021 Feb; 412():115353. PubMed ID: 33301752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
    Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4.
    Wang KS; Frank DA; Ritz J
    Blood; 2000 May; 95(10):3183-90. PubMed ID: 10807786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation.
    Lusty E; Poznanski SM; Kwofie K; Mandur TS; Lee DA; Richards CD; Ashkar AA
    Mol Immunol; 2017 Aug; 88():138-147. PubMed ID: 28644973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity.
    Micallef MJ; Tanimoto T; Torigoe K; Nishida Y; Kohno K; Ikegami H; Kurimoto M
    Cancer Immunol Immunother; 1999; 48(2-3):109-17. PubMed ID: 10414464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2.
    Hiraki A; Kiura K; Yamane H; Nogami N; Tabata M; Takigawa N; Ueoka H; Tanimoto M; Harada M
    Lung Cancer; 2002 Mar; 35(3):329-33. PubMed ID: 11844609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.